Pharmacokinetics and Pharmacodynamics of Natalizumab 6-Week Dosing vs Continued 4-Week Dosing for Relapsing-Remitting Multiple Sclerosis
那他珠单抗 6 周给药与持续 4 周给药治疗复发缓解型多发性硬化症的药代动力学和药效学
期刊:Neurology-Neuroimmunology & Neuroinflammation
影响因子:7.8
doi:10.1212/NXI.0000000000200321
John F Foley, Gilles Defer, Lana Zhovtis Ryerson, Jeffrey A Cohen, Douglas L Arnold, Helmut Butzkueven, Gary R Cutter, Gavin Giovannoni, Joep Killestein, Heinz Wiendl, Kexuan Li, Liesel Dsilva, Marie Toukam, Kyle Ferber, Jihee Sohn, Holly Engelman, Tyler Lasky
